4 June 2026
The effectiveness of REAC® technology in managing depression, anxiety and stress: Evidence from DASS-42
Treatments of neurobiological modulation REAC-NPO and REAC-NPPO in the management of anxiety, depression and stress.
News
News and updates.
Published studies, congresses and updates on REAC® Technology and ASMED® devices.
4 June 2026
11 May 2026
REAC® technology and Alzheimer's disease: a controlled clinical trial on motor effects
A randomized cross-over study evaluates the feasibility, safety and motor effects of the REAC® NPO protocol in 60 patients.
7 March 2026
Clinical performance of REAC biomodulation in the treatment of low-grade inflammation
Analysis of the clinical results of the PMCF study on the REAC ACT, CO and MO-IBZ protocols.
3 November 2025
Lipedema World Congress 2025: the REAC® Technology approach
Biomodulation protocols ACT, CO and MO based on REAC® Technology presented at the congress.
6 October 2025
REAC® Technology and Autism: the perspectives of the new European guide
Evidence on technology in children with behavioural disorder presented in the framework of the new European guide.
15 September 2025
REAC neurobiological modulation in post-stroke recovery: Analysis of NPO and NMO protocols
Analysis of the Lombardi et al. (2025) study on REAC NPO and NMO protocols in early functional recovery after stroke.
